These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37529630)

  • 1. Inflammatory phenotypes may be more important than age and comorbidities in predicting clinical outcomes in hospitalised patients with COVID-19.
    Ngiam JN; Koh MC; Liong TS; Sim MY; Chhabra S; Goh W; Chew NW; Sia CH; Goon PK; Soong JT; Tambyah PA; Cove ME
    IJID Reg; 2023 Sep; 8():84-89. PubMed ID: 37529630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative SARS-CoV-2 RT-PCR and Bronchoalveolar Cytokine Concentrations Redefine the COVID-19 Phenotypes in Critically Ill Patients.
    Vazquez Guillamet MC; Vazquez Guillamet R; Rjob A; Reynolds D; Parikh B; Despotovic V; Byers DE; Ellebedy AH; Kollef MH; Mudd PA
    J Intensive Care Med; 2024 Jun; 39(6):525-533. PubMed ID: 38629466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
    Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
    Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis.
    Evrard B; Sinha P; Delucchi K; Hendrickson CM; Kangelaris KN; Liu KD; Willmore A; Wu N; Neyton L; Schmiege E; Gomez A; Kerchberger VE; Zalucky A; Matthay MA; Ware LB; Calfee CS
    Crit Care; 2024 May; 28(1):164. PubMed ID: 38745253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
    Sinha P; Calfee CS; Cherian S; Brealey D; Cutler S; King C; Killick C; Richards O; Cheema Y; Bailey C; Reddy K; Delucchi KL; Shankar-Hari M; Gordon AC; Shyamsundar M; O'Kane CM; McAuley DF; Szakmany T
    Lancet Respir Med; 2020 Dec; 8(12):1209-1218. PubMed ID: 32861275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid Therapy Is Associated With Improved Outcome in Critically Ill Patients With COVID-19 With Hyperinflammatory Phenotype.
    Chen H; Xie J; Su N; Wang J; Sun Q; Li S; Jin J; Zhou J; Mo M; Wei Y; Chao Y; Hu W; Du B; Qiu H
    Chest; 2021 May; 159(5):1793-1802. PubMed ID: 33316235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
    Sinha P; Kerchberger VE; Willmore A; Chambers J; Zhuo H; Abbott J; Jones C; Wickersham N; Wu N; Neyton L; Langelier CR; Mick E; He J; Jauregui A; Churpek MM; Gomez AD; Hendrickson CM; Kangelaris KN; Sarma A; Leligdowicz A; Delucchi KL; Liu KD; Russell JA; Matthay MA; Walley KR; Ware LB; Calfee CS
    Lancet Respir Med; 2023 Nov; 11(11):965-974. PubMed ID: 37633303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity.
    Lui DTW; Lee CH; Chow WS; Lee ACH; Tam AR; Fong CHY; Law CY; Leung EKH; To KKW; Tan KCB; Woo YC; Lam CW; Hung IFN; Lam KSL
    Clin Endocrinol (Oxf); 2021 Sep; 95(3):469-477. PubMed ID: 33813743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host and Microbe Blood Metagenomics Reveals Key Pathways Characterizing Critical Illness Phenotypes.
    Neyton LPA; Sinha P; Sarma A; Mick E; Kalantar K; Chen S; Wu N; Delucchi K; Zhuo H; Bos LDJ; Jauregui A; Gomez A; Hendrickson CM; Kangelaris KN; Leligdowicz A; Liu KD; Matthay MA; Langelier CR; Calfee CS
    Am J Respir Crit Care Med; 2024 Apr; 209(7):805-815. PubMed ID: 38190719
    [No Abstract]   [Full Text] [Related]  

  • 12. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenotypes and Subphenotypes of Patients With COVID-19: A Latent Class Modeling Analysis.
    Wang X; Jehi L; Ji X; Mazzone PJ
    Chest; 2021 Jun; 159(6):2191-2204. PubMed ID: 33640378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An internally validated prediction model for critical COVID-19 infection and intensive care unit admission in symptomatic pregnant women.
    Kalafat E; Prasad S; Birol P; Tekin AB; Kunt A; Di Fabrizio C; Alatas C; Celik E; Bagci H; Binder J; Le Doare K; Magee LA; Mutlu MA; Yassa M; Tug N; Sahin O; Krokos P; O'brien P; von Dadelszen P; Palmrich P; Papaioannou G; Ayaz R; Ladhani SN; Kalantaridou S; Mihmanli V; Khalil A
    Am J Obstet Gynecol; 2022 Mar; 226(3):403.e1-403.e13. PubMed ID: 34582796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study.
    Uka A; Buettcher M; Bernhard-Stirnemann S; Fougère Y; Moussaoui D; Kottanattu L; Wagner N; Zimmermann P; Ritz N;
    Eur J Pediatr; 2022 Mar; 181(3):1245-1255. PubMed ID: 34845526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in electrocardiographic and cardiovascular manifestations of patients hospitalised with COVID-19.
    Ngiam JN; Liong TS; Koh MCY; Goh W; Sim MY; Chhabra S; Chew NWS; Annadurai JK; Thant SM; Chai P; Yeo TC; Poh KK; Tambyah PA; Sia CH
    Singapore Med J; 2024 Jul; ():. PubMed ID: 39028967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational diabetes mellitus and COVID-19: results from the COVID-19-Related Obstetric and Neonatal Outcome Study (CRONOS).
    Kleinwechter HJ; Weber KS; Mingers N; Ramsauer B; Schaefer-Graf UM; Groten T; Kuschel B; Backes C; Banz-Jansen C; Berghaeuser MA; Brotsack IA; Dressler-Steinbach I; Engelbrecht C; Engler-Hauschild S; Gruber TM; Hepp V; Hollatz-Galuschki E; Iannaccone A; Jebens A; von Kaisenberg CS; Kaup L; Keil C; Kladt C; Kolben T; Kraft K; Kunze M; Lastinger J; Luedemann K; Manz J; Morfeld CA; Parchmann O; Pfaff L; Reinhardt K; Runkel A; Schmidt M; Sourouni M; Stelbrink J; Stubert J; Stumpfe FM; Treptow A; Rüdiger M; Pecks U;
    Am J Obstet Gynecol; 2022 Oct; 227(4):631.e1-631.e19. PubMed ID: 35580632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisystem outcomes and predictors of mortality in critically ill patients with COVID-19: Demographics and disease acuity matter more than comorbidities or treatment modalities.
    Alser O; Mokhtari A; Naar L; Langeveld K; Breen KA; El Moheb M; Kapoen C; Gaitanidis A; Christensen MA; Maurer LR; Mashbari H; Bankhead-Kendall B; Parks J; Fawley J; Saillant N; Mendoza A; Paranjape C; Fagenholz P; King D; Lee J; Farhat MR; Velmahos GC; Kaafarani HMA
    J Trauma Acute Care Surg; 2021 May; 90(5):880-890. PubMed ID: 33891572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study.
    Gurol-Urganci I; Jardine JE; Carroll F; Draycott T; Dunn G; Fremeaux A; Harris T; Hawdon J; Morris E; Muller P; Waite L; Webster K; van der Meulen J; Khalil A
    Am J Obstet Gynecol; 2021 Nov; 225(5):522.e1-522.e11. PubMed ID: 34023315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.